rs2857824

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_201384.3(PLEC):​c.4651C>T​(p.Arg1551Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00386 in 1,579,836 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1551H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0030 ( 5 hom., cov: 36)
Exomes 𝑓: 0.0039 ( 11 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

10
8

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts P:1U:3B:6

Conservation

PhyloP100: 2.01

Publications

3 publications found
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]
PLEC Gene-Disease associations (from GenCC):
  • epidermolysis bullosa simplex
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • epidermolysis bullosa simplex 5A, Ogna type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Genomics England PanelApp
  • autosomal recessive limb-girdle muscular dystrophy type 2Q
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • epidermolysis bullosa simplex 5B, with muscular dystrophy
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Genomics England PanelApp
  • epidermolysis bullosa simplex 5C, with pyloric atresia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • epidermolysis bullosa simplex with nail dystrophy
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • aplasia cutis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cholestasis
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009919345).
BP6
Variant 8-143925278-G-A is Benign according to our data. Variant chr8-143925278-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 196717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.003 (456/151848) while in subpopulation AMR AF = 0.00759 (116/15288). AF 95% confidence interval is 0.00647. There are 5 homozygotes in GnomAd4. There are 213 alleles in the male GnomAd4 subpopulation. Median coverage is 36. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLECNM_201384.3 linkc.4651C>T p.Arg1551Cys missense_variant Exon 31 of 32 ENST00000345136.8 NP_958786.1
PLECNM_201378.4 linkc.4609C>T p.Arg1537Cys missense_variant Exon 31 of 32 ENST00000356346.7 NP_958780.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLECENST00000345136.8 linkc.4651C>T p.Arg1551Cys missense_variant Exon 31 of 32 1 NM_201384.3 ENSP00000344848.3
PLECENST00000356346.7 linkc.4609C>T p.Arg1537Cys missense_variant Exon 31 of 32 1 NM_201378.4 ENSP00000348702.3

Frequencies

GnomAD3 genomes
AF:
0.00301
AC:
456
AN:
151736
Hom.:
5
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.00107
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00760
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000662
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00411
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00247
AC:
477
AN:
193378
AF XY:
0.00237
show subpopulations
Gnomad AFR exome
AF:
0.000368
Gnomad AMR exome
AF:
0.00371
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000973
Gnomad NFE exome
AF:
0.00385
Gnomad OTH exome
AF:
0.00319
GnomAD4 exome
AF:
0.00395
AC:
5635
AN:
1427988
Hom.:
11
Cov.:
77
AF XY:
0.00374
AC XY:
2652
AN XY:
709576
show subpopulations
African (AFR)
AF:
0.000579
AC:
19
AN:
32808
American (AMR)
AF:
0.00426
AC:
185
AN:
43422
Ashkenazi Jewish (ASJ)
AF:
0.000117
AC:
3
AN:
25744
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38472
South Asian (SAS)
AF:
0.000143
AC:
12
AN:
83992
European-Finnish (FIN)
AF:
0.000779
AC:
28
AN:
35946
Middle Eastern (MID)
AF:
0.000641
AC:
3
AN:
4678
European-Non Finnish (NFE)
AF:
0.00470
AC:
5185
AN:
1103634
Other (OTH)
AF:
0.00337
AC:
200
AN:
59292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
356
711
1067
1422
1778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00300
AC:
456
AN:
151848
Hom.:
5
Cov.:
36
AF XY:
0.00287
AC XY:
213
AN XY:
74224
show subpopulations
African (AFR)
AF:
0.00106
AC:
44
AN:
41418
American (AMR)
AF:
0.00759
AC:
116
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5106
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.000662
AC:
7
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00411
AC:
279
AN:
67880
Other (OTH)
AF:
0.00427
AC:
9
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00237
Hom.:
0
Bravo
AF:
0.00368
ExAC
AF:
0.00197
AC:
219
Asia WGS
AF:
0.000290
AC:
1
AN:
3466

ClinVar

Significance: Likely benign
Submissions summary: Pathogenic:1Uncertain:3Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:4
Dec 26, 2018
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLEC: BS2 -

Sep 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27181684) -

Multiple sclerosis Pathogenic:1
Jun 10, 2024
Department of Molecular Biology and Genetics, Acibadem University
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Oct 23, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.41
.;.;.;.;T;.;.;.;.
Eigen
Uncertain
0.27
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.97
D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0099
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.090
T
MutationAssessor
Uncertain
2.0
.;.;.;.;M;.;.;.;.
PhyloP100
2.0
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-2.5
D;D;D;D;D;D;D;D;D
REVEL
Benign
0.17
Sift
Uncertain
0.0030
D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D;D;.
Vest4
0.60
MVP
0.66
ClinPred
0.021
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.9
Varity_R
0.070
gMVP
0.41
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2857824; hg19: chr8-144999446; API